Halozyme to Report First Quarter 2026 Financial and Operating Results

P SAN DIEGO, April 30, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme”) today announced it will release its first quarter 2026 financial and…
posteditor
posteditor
Articles: 27509

Other News